Efficient delivery of payload into tumor cells in a controlled manner by TAT and thiolytic cleavable PEG co-modified liposomes.
about
Recent trends in multifunctional liposomal nanocarriers for enhanced tumor targetingPolyethylene glycol-poly(ε-benzyloxycarbonyl-l-lysine)-conjugated VEGF siRNA for antiangiogenic gene therapy in hepatocellular carcinoma.Transferrin and cell-penetrating peptide dual-functioned liposome for targeted drug delivery to glioma.Synthesis and in vitro evaluation of pH-sensitive PEG-I-dC16 block polymer micelles for anticancer drug delivery.A detachable coating of cholesterol-anchored PEG improves tumor targeting of cell-penetrating peptide-modified liposomesOptimization of Non-Viral Gene Therapeutics Using Bilamellar Invaginated Vesicles.Delivery of intracellular-acting biologics in pro-apoptotic therapies.Harnessing the power of cell-penetrating peptides: activatable carriers for targeting systemic delivery of cancer therapeutics and imaging agents.Curb challenges of the "Trojan Horse" approach: smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery.Significantly enhanced tumor cellular and lysosomal hydroxychloroquine delivery by smart liposomes for optimal autophagy inhibition and improved antitumor efficiency with liposomal doxorubicinGE11-modified liposomes for non-small cell lung cancer targeting: preparation, ex vitro and in vivo evaluationTumor targeting of a cell penetrating peptide by fusing with a pH-sensitive histidine-glutamate co-oligopeptide.Designer vaccine nanodiscs for personalized cancer immunotherapy.Peptide targeted lipid nanoparticles for anticancer drug delivery.Targeted delivery of nano-therapeutics for major disorders of the central nervous system.Bioreducible polycations as shuttles for therapeutic nucleic acid and protein transfection.The interaction of nanoparticles with plasma proteins and the consequent influence on nanoparticles behavior.Expression of IARS2 gene in colon cancer and effect of its knockdown on biological behavior of RKO cells.Co-delivery of doxorubicin and P-gp inhibitor by a reduction-sensitive liposome to overcome multidrug resistance, enhance anti-tumor efficiency and reduce toxicity.Folate and TAT peptide co-modified liposomes exhibit receptor-dependent highly efficient intracellular transport of payload in vitro and in vivo.Liposomes co-modified with cholesterol anchored cleavable PEG and octaarginines for tumor targeted drug delivery.Nanoescapology: progress toward understanding the endosomal escape of polymeric nanoparticles.Anti-tumor effect of RGD modified PTX loaded liposome on prostatic cancer.Reversible masking using low-molecular-weight neutral lipids to achieve optimal-targeted delivery.Targeting hepatic cancer cells with pegylated dendrimers displaying N-acetylgalactosamine and SP94 peptide ligands.Cleavable PEGylation: a strategy for overcoming the "PEG dilemma" in efficient drug delivery.Disulfide-bridged cleavable PEGylation in polymeric nanomedicine for controlled therapeutic delivery.Increased Active Tumor Targeting by An αvβ3-Targeting and Cell-Penetrating Bifunctional Peptide-Mediated Dendrimer-Based Conjugate.Application of Light Scattering Techniques to Nanoparticle Characterization and Development.
P2860
Q30456053-7C39669E-2614-4B7B-ACC1-DD5E660CC572Q33686536-4313F654-C73F-48EF-8AE8-310291B431BBQ35479189-E576FA48-6834-43A7-B16F-6F2BCE9D446EQ35971215-DD35EBA8-20BC-4731-883F-3DA3B3BE18BDQ36110850-08B84B73-8317-485A-B2DC-CBEB7F923956Q36334067-A0F3C3CF-452F-4B21-A815-64EB94220A4AQ36588920-F7ED370D-864F-423C-9F32-C16156F77086Q36612939-5F26154E-01A7-484D-BDA3-706918F43514Q36854231-FDAEB9FE-559E-403C-8AD9-0C58B6F456C1Q37041531-1BEABF96-D19C-41D5-A3BE-B71C21548714Q37591930-FCA1E2E4-1228-4C43-9727-E7159789B34AQ37638246-BD93ED5C-C18B-4F6A-8FD6-7C5D80F19072Q37730767-69FFB433-5A71-4DA8-AC6C-96468BF7434DQ38016810-CC1BD2B3-7E89-47F6-B868-6AA15A8C2DF4Q38116765-332E8E8C-E654-471F-BCA1-DD042D27E261Q38161927-4F4935B4-F13F-48CE-A29F-570470809363Q38176391-A5466DFF-14B4-401E-935D-725F0E1C8DFFQ38807237-749AE25D-9F29-4F8E-8DAC-87CFCE25B665Q38930537-5A4AA433-49AF-4E8F-9D31-A6EA0F885B40Q38991983-B42DBD73-D957-48AB-BFBA-04E3F6ACB3F0Q39036112-B24C676D-22DD-4B2E-89D7-C929C06683C0Q39119319-EFA23044-A0E3-42C1-9CC6-6E1F5E1BAE0AQ41880095-456A2E91-4233-4D5D-B4E6-69A33DB58F8FQ42177203-3EEB6CF7-D804-4C7F-90D1-5A033D2777EAQ43845180-57236BB2-4386-4E8A-8D4D-7B94A6AF0F45Q47288830-5C84D9C8-B3F5-4745-A9B0-877E41C567BDQ50957676-5171DCB8-19F5-4D57-841D-3843B7CDBC9BQ52812169-C62BA03C-834A-4D24-9046-2199D204F169Q55516366-3AB08FA8-8EC5-4527-95C5-2C25049882C7
P2860
Efficient delivery of payload into tumor cells in a controlled manner by TAT and thiolytic cleavable PEG co-modified liposomes.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Efficient delivery of payload ...... ble PEG co-modified liposomes.
@ast
Efficient delivery of payload ...... ble PEG co-modified liposomes.
@en
type
label
Efficient delivery of payload ...... ble PEG co-modified liposomes.
@ast
Efficient delivery of payload ...... ble PEG co-modified liposomes.
@en
prefLabel
Efficient delivery of payload ...... ble PEG co-modified liposomes.
@ast
Efficient delivery of payload ...... ble PEG co-modified liposomes.
@en
P2093
P356
P1476
Efficient delivery of payload ...... able PEG co-modified liposomes
@en
P2093
Huali Chen
Mingqing Yuan
Wenmin Yuan
Zhirong Zhang
P304
P356
10.1021/MP100171C
P407
P50
P577
2010-08-11T00:00:00Z